Genaera Cp (GENR)

Company Overview
Genaera Corporation, a biopharmaceutical company, engages in the research and development of medicines with focus on antiangiogenesis and respiratory diseases. The company’s primary product EVIZON is under Phase II and Phase III clinical trials to treat ophthalmic indications, specifically the ‘wet’ form of age related macular degeneration. It is also developing Squalamine Lactate, a Phase II clinical trial product, for the treatment of cancerous solid tumors; LOMUCIN, a Phase II clinical trial product, to treat the overproduction of mucus secretions involved in chronic respiratory disease; and interleukin-9 antibody, a respiratory treatment based on the discovery of a...
read more

QUOTE

As of 08:17PM EDT July 23, 2014
$ N/A   N/A (N/A%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: N/A
52 Week High: N/A Bid (size): N/A
52 Week Low: N/A Ask (size): N/A

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 6109415231
Mailing Address: 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Phone: 610-941-4020
Fax: 610-941-5399
Website: http://www.genaera.com

Company Details:

Symbol: GENR
SIC: 880431
State location: PA
Sector: -
State of Inc: DE
Employees: 24
Type: NASDAQ

Key executives:

Name Age Position

LATEST ARTICLES

LATEST STOCK PROMOTIONS

Genaera Cp (GENR) MESSAGE BOARD

Post # Subject Re Name Date
1 This message board is to discuss Genaera... 0
2 Here on this message board we are inviting... 0